Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin. Latest News 2023 Grant Recipients BRCA Research and Cure Alliance News | June 2023 Katherine Nathanson, MD, Director of Genetics at the Basser Center, on her new research endeavor: “Expanding The Spectrum of BRCA1/2 Pathogenic Variants” funded by BRCA Research and Cure Alliance. The Next Big Advance in Cancer Treatment Could Be a Vaccine Associated Press News | June 2023 Scientists say research has reached a turning point, with many predicting more vaccines will be out in five years. Susan M. Domchek, MD, executive director of the Basser Center, and her work in recruiting healthy people with BRCA mutations for the vaccine test are mentioned. Progress in BRCA-Related Cancers Highlighted By the Basser Center Let's Win Pancreatic Cancer News | June 2023 Let's Win recaps our 2023 Breakthroughs & Discoveries Panel from the 11th Annual Basser Center Scientific Symposium. The broad-ranging discussion among experts in the field focused on screening and treatment for BRCA-related cancer, cancer interception and prevention, and more. Multiple Trials Underway to Create a Breast Cancer Vaccine Deseret News News | May 2023 The Deseret News covered efforts to create a vaccine for breast cancer. Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, and Susan M. Domchek, MD, executive director of the Basser Center, were quoted. Veterans More Likely to Get Genetic Testing with In-Person Consults Genome Web News | May 2023 Veterans, particularly those who self-identified as Black, were more likely to get germline genetic cancer testing within an in-person nurse-led program at a Veterans Affairs medical center than through a telehealth genetics program, according to a study led by Kara Maxwell, MD, PhD, an assistant professor of Genetics and Basser's Men & BRCA Program Director. Eradicate Breast Cancer? The Hunt for a Vaccine Looks Promising Bloomberg News | May 2023 The arrival of not just one but several breast cancer vaccine studies is an encouraging sign of the progress researchers are making in harnessing the immune system to not just battle cancer, but prevent it in the first place. Susan M. Domchek, MD, executive director of the Basser Center, is leading a trial of a preventive breast cancer vaccine at Penn Medicine’s ACC. “It’s not just pie in the sky, we’re actually doing it,” she said. What You Should Know About Genetic Testing and How it Can Save Lives Penn Live News | May 2023 Jacquelyn Powers, MS, LCGC, associate director of Genetic Counseling at the Basser Center for BRCA, explained how genetic counseling and testing can identify cancer risk and help prevent or catch it early. Genetic Sequencing May Identify Cancers Often Missed by Traditional Screening Guidelines The ASCO Post News | May 2023 Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research, commented on a large study about genetic sequencing for hereditary cancer syndromes presented at the AACR Annual Meeting in April 2023. She noted the results were consistent with other studies and reinforce the importance of taking a good family history to identify patients who should be referred to genetic counseling and testing. Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer Prostate Cancer Foundation News | May 2023 Research led by Kara Maxwell, MD, PhD, the Pearl and Philip Basser Innovation Research Award recipient and the director of the Men & BRCA Program, finds an embedded on-site genetics nurse can help reduce barriers to germline testing and improve genetic care for at-risk patients and families. Folding@home: How You, and Your Computer, Can Play Scientist Penn Medicine News News | May 2023 Gregory Bowman, PhD hopes to uncover how to drug proteins related to the BRCA1 and BRCA2 genes which, when mutated, can lead to breast, ovarian, prostate, and pancreatic cancers. Six Warning Signs of Ovarian Cancer Daily Mail News | May 2023 “Ovarian cancer is often said to be a silent killer because it doesn’t have early symptoms, when in fact it does have symptoms, they’re just very general and could be caused by other things,” explained Ronny Drapkin, MD, PhD, director of the Ovarian Cancer Research Center, and Gynecologic Cancer Research, in the Basser Center for BRCA. New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe Boston Globe News | May 2023 A new study found that allowing a break in hormone suppression therapy to allow breast cancer survivors the chance to get pregnant and breastfeed did not appear to increase the risk of cancer recurring. Susan M. Domchek, MD, executive director of the Basser Center, who was not involved in the study, described the findings as “a gift we can give our patients." BRCA Mutations in Men: Three Things to Know Penn Medicine News News | May 2023 Learn what men should know about BRCA gene mutations from Kara Maxwell, MD, PhD, director of the Men & BRCA Program at the Basser Center for BRCA. AACR Annual Meeting Highlights Showcased in Final Plenary Session American Association for Cancer Research News | April 2023 During the final session of the AACR Annual Meeting 2023, Program Committee Chair Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, reviewed significant highlights and important themes from the meeting. “We have made progress and we have a lot more to do,” he said. Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years American Association for Cancer Research News | April 2023 Gregory R. Bowman, PhD, the first researcher funded by the Basser Cancer Interception Institute (BCII) and Professor of Biochemistry & Biophysics and Bioengineering, shared his team’s work using a neural network to find hidden pockets in proteins that could potentially be targeted with drugs to treat cancer. Broadening Cancer Screening with Whole-Exome Sequencing Cancer Discovery News | April 2023 A retrospective analysis presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting showed that whole-exome sequencing is an effective tool to identify people with hereditary cancer-predisposing conditions who would not meet current criteria for preventive screening. Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments Penn Medicine News News | April 2023 Penn Medicine has cemented its identity as a place that incubates and brings to life some of the most transformative modern medical advancements. Science has shifted toward more discoveries based on the underlying mechanism of disease, especially in new cancer drug discovery. AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine American Association of Cancer Research News | April 2023 “From cutting-edge basic science and translational science all the way into population science, we’re going to learn about trial results that will change practice,” Robert H. Vonderheide, MD, DPhil, director of the Penn Medicine Abramson Cancer Center said. Pagination First page« First Previous page‹‹ Page1 Page2 Page3 Current page4 Page5 Page6 Page7 Page8 Page9 … Next page›› Last pageLast »
Basser Center for BRCA Celebrates Breast Cancer Awareness Month TODAY News Susan Domchek, MD, executive director of the Basser Center, took part in a live interview on the TODAY Show with breast cancer survivor and Basser Advisory Board member Jill Martin.
2023 Grant Recipients BRCA Research and Cure Alliance News | June 2023 Katherine Nathanson, MD, Director of Genetics at the Basser Center, on her new research endeavor: “Expanding The Spectrum of BRCA1/2 Pathogenic Variants” funded by BRCA Research and Cure Alliance.
The Next Big Advance in Cancer Treatment Could Be a Vaccine Associated Press News | June 2023 Scientists say research has reached a turning point, with many predicting more vaccines will be out in five years. Susan M. Domchek, MD, executive director of the Basser Center, and her work in recruiting healthy people with BRCA mutations for the vaccine test are mentioned.
Progress in BRCA-Related Cancers Highlighted By the Basser Center Let's Win Pancreatic Cancer News | June 2023 Let's Win recaps our 2023 Breakthroughs & Discoveries Panel from the 11th Annual Basser Center Scientific Symposium. The broad-ranging discussion among experts in the field focused on screening and treatment for BRCA-related cancer, cancer interception and prevention, and more.
Multiple Trials Underway to Create a Breast Cancer Vaccine Deseret News News | May 2023 The Deseret News covered efforts to create a vaccine for breast cancer. Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, and Susan M. Domchek, MD, executive director of the Basser Center, were quoted.
Veterans More Likely to Get Genetic Testing with In-Person Consults Genome Web News | May 2023 Veterans, particularly those who self-identified as Black, were more likely to get germline genetic cancer testing within an in-person nurse-led program at a Veterans Affairs medical center than through a telehealth genetics program, according to a study led by Kara Maxwell, MD, PhD, an assistant professor of Genetics and Basser's Men & BRCA Program Director.
Eradicate Breast Cancer? The Hunt for a Vaccine Looks Promising Bloomberg News | May 2023 The arrival of not just one but several breast cancer vaccine studies is an encouraging sign of the progress researchers are making in harnessing the immune system to not just battle cancer, but prevent it in the first place. Susan M. Domchek, MD, executive director of the Basser Center, is leading a trial of a preventive breast cancer vaccine at Penn Medicine’s ACC. “It’s not just pie in the sky, we’re actually doing it,” she said.
What You Should Know About Genetic Testing and How it Can Save Lives Penn Live News | May 2023 Jacquelyn Powers, MS, LCGC, associate director of Genetic Counseling at the Basser Center for BRCA, explained how genetic counseling and testing can identify cancer risk and help prevent or catch it early.
Genetic Sequencing May Identify Cancers Often Missed by Traditional Screening Guidelines The ASCO Post News | May 2023 Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research, commented on a large study about genetic sequencing for hereditary cancer syndromes presented at the AACR Annual Meeting in April 2023. She noted the results were consistent with other studies and reinforce the importance of taking a good family history to identify patients who should be referred to genetic counseling and testing.
Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer Prostate Cancer Foundation News | May 2023 Research led by Kara Maxwell, MD, PhD, the Pearl and Philip Basser Innovation Research Award recipient and the director of the Men & BRCA Program, finds an embedded on-site genetics nurse can help reduce barriers to germline testing and improve genetic care for at-risk patients and families.
Folding@home: How You, and Your Computer, Can Play Scientist Penn Medicine News News | May 2023 Gregory Bowman, PhD hopes to uncover how to drug proteins related to the BRCA1 and BRCA2 genes which, when mutated, can lead to breast, ovarian, prostate, and pancreatic cancers.
Six Warning Signs of Ovarian Cancer Daily Mail News | May 2023 “Ovarian cancer is often said to be a silent killer because it doesn’t have early symptoms, when in fact it does have symptoms, they’re just very general and could be caused by other things,” explained Ronny Drapkin, MD, PhD, director of the Ovarian Cancer Research Center, and Gynecologic Cancer Research, in the Basser Center for BRCA.
New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe Boston Globe News | May 2023 A new study found that allowing a break in hormone suppression therapy to allow breast cancer survivors the chance to get pregnant and breastfeed did not appear to increase the risk of cancer recurring. Susan M. Domchek, MD, executive director of the Basser Center, who was not involved in the study, described the findings as “a gift we can give our patients."
BRCA Mutations in Men: Three Things to Know Penn Medicine News News | May 2023 Learn what men should know about BRCA gene mutations from Kara Maxwell, MD, PhD, director of the Men & BRCA Program at the Basser Center for BRCA.
AACR Annual Meeting Highlights Showcased in Final Plenary Session American Association for Cancer Research News | April 2023 During the final session of the AACR Annual Meeting 2023, Program Committee Chair Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, reviewed significant highlights and important themes from the meeting. “We have made progress and we have a lot more to do,” he said.
Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years American Association for Cancer Research News | April 2023 Gregory R. Bowman, PhD, the first researcher funded by the Basser Cancer Interception Institute (BCII) and Professor of Biochemistry & Biophysics and Bioengineering, shared his team’s work using a neural network to find hidden pockets in proteins that could potentially be targeted with drugs to treat cancer.
Broadening Cancer Screening with Whole-Exome Sequencing Cancer Discovery News | April 2023 A retrospective analysis presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting showed that whole-exome sequencing is an effective tool to identify people with hereditary cancer-predisposing conditions who would not meet current criteria for preventive screening.
Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments Penn Medicine News News | April 2023 Penn Medicine has cemented its identity as a place that incubates and brings to life some of the most transformative modern medical advancements. Science has shifted toward more discoveries based on the underlying mechanism of disease, especially in new cancer drug discovery.
AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine American Association of Cancer Research News | April 2023 “From cutting-edge basic science and translational science all the way into population science, we’re going to learn about trial results that will change practice,” Robert H. Vonderheide, MD, DPhil, director of the Penn Medicine Abramson Cancer Center said.
